SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001126234-23-000091
Filing Date
2023-08-10
Accepted
2023-08-10 09:32:55
Documents
48
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q nlnk-20230630.htm   iXBRL 10-Q 1280876
2 EX-31.1 lumo-20233630x10qxex311.htm EX-31.1 10026
3 EX-31.2 lumo-2023630x10qxex312.htm EX-31.2 10076
4 EX-32.1 lumo-2023630x10qxex321.htm EX-32.1 7060
10 nlnk-20230630_g1.jpg GRAPHIC 12762
11 nlnk-20230630_g2.jpg GRAPHIC 136855
  Complete submission text file 0001126234-23-000091.txt   4671703

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nlnk-20230630.xsd EX-101.SCH 24022
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nlnk-20230630_cal.xml EX-101.CAL 41056
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nlnk-20230630_def.xml EX-101.DEF 98422
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nlnk-20230630_lab.xml EX-101.LAB 335502
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nlnk-20230630_pre.xml EX-101.PRE 197483
42 EXTRACTED XBRL INSTANCE DOCUMENT nlnk-20230630_htm.xml XML 470028
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35342 | Film No.: 231157579
SIC: 2834 Pharmaceutical Preparations